Orchid Pharma Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Manish Dhanuka
Chief executive officer
₹35.5m
Total compensation
| CEO salary percentage | 22.3% |
| CEO tenure | 4.4yrs |
| CEO ownership | n/a |
| Management average tenure | 4.4yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Earnings Tell The Story For Orchid Pharma Limited (NSE:ORCHPHARMA) As Its Stock Soars 26%
Jul 29
We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | ₹36m | ₹8m | ₹922m |
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹775m |
| Mar 31 2023 | ₹12m | ₹8m | ₹531m |
| Dec 31 2022 | n/a | n/a | -₹175m |
| Sep 30 2022 | n/a | n/a | -₹356m |
| Jun 30 2022 | n/a | n/a | -₹471m |
| Mar 31 2022 | ₹7m | ₹7m | -₹604m |
| Dec 31 2021 | n/a | n/a | -₹592m |
| Sep 30 2021 | n/a | n/a | -₹934m |
| Jun 30 2021 | n/a | n/a | -₹1b |
| Mar 31 2021 | ₹5m | ₹5m | -₹952m |
Compensation vs Market: Manish's total compensation ($USD421.18K) is about average for companies of similar size in the Indian market ($USD355.98K).
Compensation vs Earnings: Manish's compensation has increased by more than 20% in the past year.
CEO
Manish Dhanuka (57 yo)
4.4yrs
Tenure
₹35,510,053
Compensation
Shri. Manish Dhanuka serves as Director at Orchid Pharma Limited since March 31, 2020 and serves as its Managing Director since June 29, 2020. He serves as Non-Executive Non-Independent Director since Nove...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 4.4yrs | ₹35.51m | no data | |
| Chief Financial Officer | 4.4yrs | ₹5.48m | no data | |
| Company Secretary & Compliance Officer | less than a year | ₹429.00k | no data | |
| Whole Time Director | 4.4yrs | ₹35.51m | no data | |
| Head of Human Resources | 23.8yrs | no data | no data | |
| President of API | no data | ₹6.68m | no data | |
| VP and Unit Head of API & FDF | no data | no data | no data | |
| Head of CTD & IPM | no data | no data | no data | |
| Chief Executive Officer of Orchid AMS | less than a year | no data | no data | |
| Head of Medico Marke | less than a year | no data | no data | |
| Head of Information Technology | 17.8yrs | no data | no data |
4.4yrs
Average Tenure
55.5yo
Average Age
Experienced Management: ORCHPHARMA's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 4.7yrs | ₹35.51m | no data | |
| Whole Time Director | 4.7yrs | ₹35.51m | no data | |
| Non Executive Chairman | 4.7yrs | no data | no data | |
| Additional Non-Executive & Independent Director | 4.4yrs | ₹285.00k | no data | |
| Additional Independent Non-Executive Director | less than a year | no data | no data | |
| Additional Non Executive Independent & Woman Director | 4.4yrs | ₹245.00k | no data | |
| Additional Non Executive & Independent Director | 4.4yrs | ₹260.00k | no data | |
| Additional Non-Executive & Non-Independent Director | 1.1yrs | ₹100.00k | no data |
4.4yrs
Average Tenure
48yo
Average Age
Experienced Board: ORCHPHARMA's board of directors are considered experienced (4.4 years average tenure).